282 related articles for article (PubMed ID: 18805611)
1. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
[TBL] [Abstract][Full Text] [Related]
2. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
Wei X; Li J; Zhan X; Tu L; Huang H; Wang Y
J Med Case Rep; 2022 Mar; 16(1):101. PubMed ID: 35241161
[TBL] [Abstract][Full Text] [Related]
3. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.
Ranghino A; Tognarelli G; Basso E; Messina M; Manzione AM; Daidola G; Segoloni GP
Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049
[TBL] [Abstract][Full Text] [Related]
4. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
[TBL] [Abstract][Full Text] [Related]
5. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
[TBL] [Abstract][Full Text] [Related]
6. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor.
Donne RL; Abbs I; Barany P; Elinder CG; Little M; Conlon P; Goodship TH
Am J Kidney Dis; 2002 Dec; 40(6):E22. PubMed ID: 12460067
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
[TBL] [Abstract][Full Text] [Related]
9. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.
Sullivan M; Erlic Z; Hoffmann MM; Arbeiter K; Patzer L; Budde K; Hoppe B; Zeier M; Lhotta K; Rybicki LA; Bock A; Berisha G; Neumann HP
Ann Hum Genet; 2010 Jan; 74(1):17-26. PubMed ID: 20059470
[TBL] [Abstract][Full Text] [Related]
11. A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.
Geelen J; van den Dries K; Roos A; van de Kar N; de Kat Angelino C; Klasen I; Monnens L; van den Heuvel L
Pediatr Nephrol; 2007 Mar; 22(3):371-5. PubMed ID: 17106690
[TBL] [Abstract][Full Text] [Related]
12. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.
Kavanagh D; Kemp EJ; Mayland E; Winney RJ; Duffield JS; Warwick G; Richards A; Ward R; Goodship JA; Goodship TH
J Am Soc Nephrol; 2005 Jul; 16(7):2150-5. PubMed ID: 15917334
[TBL] [Abstract][Full Text] [Related]
13. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic Uremic Syndrome in Pregnancy and Postpartum.
Bruel A; Kavanagh D; Noris M; Delmas Y; Wong EKS; Bresin E; Provôt F; Brocklebank V; Mele C; Remuzzi G; Loirat C; Frémeaux-Bacchi V; Fakhouri F
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1237-1247. PubMed ID: 28596415
[TBL] [Abstract][Full Text] [Related]
15. Age-related penetrance of hereditary atypical hemolytic uremic syndrome.
Sullivan M; Rybicki LA; Winter A; Hoffmann MM; Reiermann S; Linke H; Arbeiter K; Patzer L; Budde K; Hoppe B; Zeier M; Lhotta K; Bock A; Wiech T; Gaspert A; Fehr T; Woznowski M; Berisha G; Malinoc A; Goek ON; Eng C; Neumann HP
Ann Hum Genet; 2011 Nov; 75(6):639-47. PubMed ID: 21906045
[TBL] [Abstract][Full Text] [Related]
16. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic uremic syndrome recurrence after renal transplantation.
Loirat C; Fremeaux-Bacchi V
Pediatr Transplant; 2008 Sep; 12(6):619-29. PubMed ID: 18482212
[TBL] [Abstract][Full Text] [Related]
19. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.
Bresin E; Daina E; Noris M; Castelletti F; Stefanov R; Hill P; Goodship TH; Remuzzi G;
Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
